138 related articles for article (PubMed ID: 29421658)
1. Polyene phosphatidylcholine overcomes oxaliplatin resistance in human gastric cancer BGC823 cells.
Zhang H; Song H; Yuan R; Zhang X; Yu H; Zhao Y; Jiang T
Biochem Biophys Res Commun; 2018 Feb; 497(1):108-114. PubMed ID: 29421658
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro.
Zhao Q; Zhang H; Li Y; Liu J; Hu X; Fan L
J Exp Clin Cancer Res; 2010 Aug; 29(1):118. PubMed ID: 20799994
[TBL] [Abstract][Full Text] [Related]
3. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
Qin B; Tanaka R; Shibata Y; Arita S; Ariyama H; Kusaba H; Baba E; Harada M; Nakano S
Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
5. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
[TBL] [Abstract][Full Text] [Related]
6. EphA2 affects the sensitivity of oxaliplatin by inducing EMT in oxaliplatin-resistant gastric cancer cells.
Wen Q; Chen Z; Chen Z; Chen J; Wang R; Huang C; Yuan W
Oncotarget; 2017 Jul; 8(29):47998-48011. PubMed ID: 28624791
[TBL] [Abstract][Full Text] [Related]
7. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance.
Harada K; Sakamoto N; Ukai S; Yamamoto Y; Pham QT; Taniyama D; Honma R; Maruyama R; Takashima T; Ota H; Takemoto Y; Tanabe K; Ohdan H; Yasui W
Gastric Cancer; 2021 Nov; 24(6):1264-1277. PubMed ID: 34272617
[TBL] [Abstract][Full Text] [Related]
8. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of recombinant human growth hormone on growth of human gastric cancer cell line BGC823 cells.
Chen JY; Liang DM; Gan P; Zhang Y; Lin J
World J Gastroenterol; 2004 Apr; 10(8):1132-6. PubMed ID: 15069712
[TBL] [Abstract][Full Text] [Related]
11. Txr1: an important factor in oxaliplatin resistance in gastric cancer.
Bi J; Bai Z; Ma X; Song J; Guo Y; Zhao J; Yi X; Han S; Zhang Z
Med Oncol; 2014 Feb; 31(2):807. PubMed ID: 24362794
[TBL] [Abstract][Full Text] [Related]
12. Effect of oxaliplatin combined with polyenephosphatidylcholine on the proliferation of human gastric cancer SGC-7901 cells.
Jiang T; Zhang H; Liu X; Song H; Yao R; Li J; Zhao Y
Oncol Lett; 2016 Dec; 12(6):4538-4546. PubMed ID: 28101212
[TBL] [Abstract][Full Text] [Related]
13. [Impact of S100P expression on clinical outcomes of gastric cancer patients with adjuvant chemotherapy of oxaliplatin and its mechanisms].
Zhao XM; Bai ZG; Ma XM; Zhang ZT; Shi XY
Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):1004-8. PubMed ID: 21054985
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines.
Luo HY; Wei W; Shi YX; Chen XQ; Li YH; Wang F; Qiu MZ; Li FH; Yan SL; Zeng MS; Huang P; Xu RH
Oncol Rep; 2010 Jun; 23(6):1735-45. PubMed ID: 20428833
[TBL] [Abstract][Full Text] [Related]
15. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP.
Tang H; Liu YJ; Liu M; Li X
Anticancer Drugs; 2007 Jul; 18(6):633-9. PubMed ID: 17762391
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
Fu Q; Cheng J; Zhang J; Zhang Y; Chen X; Xie J; Luo S
Oncol Rep; 2016 Dec; 36(6):3682-3690. PubMed ID: 27779719
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death.
Tassone P; Tagliaferri P; Galea E; Palmieri C; Bonelli P; Martelli ML; Tuccillo F; Turco MC; Venuta S
Eur J Cancer; 2002 May; 38(8):1141-7. PubMed ID: 12008204
[TBL] [Abstract][Full Text] [Related]
18. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
19. Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells.
Takahashi K; Tanaka M; Yashiro M; Matsumoto M; Ohtsuka A; Nakayama KI; Izumi Y; Nagayama K; Miura K; Iwao H; Shiota M
Cancer Lett; 2016 Aug; 378(1):8-15. PubMed ID: 27157913
[TBL] [Abstract][Full Text] [Related]
20. Low-dose oxaliplatin enhances the antitumor efficacy of paclitaxel in human gastric cancer cell lines.
Gu J; Yamamoto H; Lu X; Ngan CY; Tsujino T; Konishi K; Takemasa I; Ikeda M; Nagata H; Hashimoto S; Matsuzaki T; Sekimoto M; Takagi A; Monden M
Digestion; 2006; 74(1):19-27. PubMed ID: 16988507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
